The Role of Anti-Thymocyte Globulin in Allogeneic Stem Cell Transplantation (HSCT) from HLA-Matched Unrelated Donors (MUD) for Secondary AML in Remission: A Study from the ALWP /EBMT

Researchers compared outcomes, of 1609 patients with secondary AML undergoing HSCT in first complete remission from MUD from 2010 to 2021, receiving or not receiving anti-thymocyte globulin.